BusinessVital Therapies Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public OfferingBy Nasdaq OMXMar 29, 2017, 8:06 PM UTC
BusinessVital Therapies Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public OfferingBy Nasdaq OMXMar 29, 2017, 8:06 PM UTC
BusinessVital Therapies Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public OfferingBy Nasdaq OMXMar 29, 2017, 8:06 PM UTC
BusinessNaturally Splendid to Appear in the Canadian Cannabis Investor Magazine and on the U.S. Cannabis Investor WebcastBy Nasdaq OMXMar 29, 2017, 5:52 PM UTC
BusinessNeothetics to Present at the 16th Annual Needham Healthcare ConferenceBy Nasdaq OMXMar 29, 2017, 12:00 PM UTC
BusinessAxsome Therapeutics Announces Full Exercise of Underwriter’s Option to Purchase Additional SharesBy Nasdaq OMXMar 29, 2017, 11:01 AM UTC
BusinessTonix Pharmaceuticals to Present FDA Breakthrough Therapy-Designated PTSD Program at The MicroCap ConferenceBy Nasdaq OMXMar 29, 2017, 11:01 AM UTC
BusinessCyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial ResultsBy Nasdaq OMXMar 28, 2017, 8:05 PM UTC
